← Back to Search

Behavioral Intervention

Mindfulness for Reducing Colorectal Cancer Risk (MindCRC Trial)

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4 and post-intervention at week 9
Awards & highlights

Summary

"This trial aims to study how practicing mindfulness can help reduce stress and lower the risk of colorectal cancer in Black American women living in neighborhoods with high levels of stress and violence."

Who is the study for?
This trial is for Black American women at an elevated risk of colorectal cancer who live in high-stress neighborhoods in Chicago. Participants should be interested in practicing mindfulness to potentially reduce their cancer risk.
What is being tested?
The study is testing whether practicing mindfulness can help lower chronic psychosocial stress (CPS) and, as a result, reduce the risk factors associated with colorectal cancer development.
What are the potential side effects?
Mindfulness practices are generally considered safe but may include temporary feelings of discomfort, emotional distress, or increased anxiety when confronting difficult thoughts or feelings.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4 and post-intervention at week 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 and post-intervention at week 9 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Feasibility measures
Other study objectives
Adiposity
Blood lipids
Body mass index
+11 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: MindfulnessExperimental Treatment1 Intervention
8-week group and individual mindfulness training and practice
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness
2014
Completed Phase 2
~3200

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
632 Previous Clinical Trials
1,567,675 Total Patients Enrolled
~27 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top